You are here: Industry Insights > tuberculosis

News List

FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs worldpharmanews
August 16, 2019
The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis (TB) of the lungs.
FDA Approves Pretomanid for Highly Drug-Resistant Forms of Tuberculosis drugs
August 15, 2019
Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA) for treating some of the most drug-resistant forms of tuberculosis (TB).
Thermally-stable TB vaccine developed using new technique europeanpharmaceuticalreview
August 09, 2019
A new process developed by the University of Bath protects a TB antigen and a novel vaccine adjuvant from heat damage.
Recs Updated for TB Screening, Treatment in Health Care Workers drugs
May 17, 2019
Recs Updated for TB Screening, Treatment in Health Care Workers.
Short Regimen Noninferior for Rifampin-Resistant Tuberculosis drugs
March 14, 2019
A short regimen is noninferior to a long regimen for patients with rifampin-resistant tuberculosis that is susceptible to fluoroquinolones and aminoglycosides, according to a study published online March 13 in the New England Journal of Medicine.
Researchers develop new treatment for TB pharmaceutical-technology
January 10, 2019
A team of researchers has developed a novel treatment for tuberculosis (TB), which has the potential to be ‘scaled-up’ for clinical testing.
MSF warns high prices of tuberculosis drug expressbpd
October 25, 2018
Calls on US pharma corporation Johnson & Johnson to cut key TB drug price in half
WHO calls for urgent action to end TB biospectrum
September 21, 2018
WHO’s 2018 Global TB Report, released in New York recently, calls for an unprecedented mobilization of national and international commitments.
New approach to fight tuberculosis, a leading cause of death worldwide worldpharmanews
August 20, 2018
Tuberculosis is one of the top 10 causes of death worldwide. Nearly 2 million people die every year from this infectious disease, and an estimated 2 billion people are chronically infected.
Studies find shorter tuberculosis therapy more effective and safe pharmaceutical-technology
August 07, 2018
Two clinical studies carried out by Research-Institute of the McGill University Health Centre (RI-MUHC) in Canada have shown that a shorter therapy for tuberculosis (TB) is more effective and safe in both children and adults when compared to existing stan

Previous page 1 2 3 4 Next page